John O’Mullane, group vice-president, R&D, Schering-Plough Consumer Health Care, said: “Schering-Plough is pleased that the FDA has approved the change to the Claritin label to help us to communicate to consumers that Claritin works hard to relieve both indoor and outdoor allergies.”